Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Immunoglobulin E
100%
Macrophage
91%
Chondroitin Sulfate Proteoglycan
76%
Immunotherapy
55%
Effector Cell
49%
Basophil
46%
Immunoglobulin E Antibody
40%
Trastuzumab
38%
Gamma Urogastrone
38%
Cancer Tissue
38%
Melanoma Antigen
38%
Disease Burden
38%
B Cell
38%
Natural Killer Cell
28%
Antibody-Dependent Cell-Mediated Cytotoxicity
27%
Xenograft
24%
Tumor Cell
24%
Normal Human
23%
Immunocompetent Cell
20%
Cell Surface
20%
Adjuvant
19%
Tumor Volume
19%
Survival Rate
19%
Cell Killing
19%
Cell Membrane
19%
Antibody Design
19%
Wild Type
19%
Point Mutation
19%
Fc Receptor
18%
Monoclonal Antibody
15%
Immunoglobulin G4
14%
Immune Response
12%
Cytokine
12%
Cytokine Production
12%
Tumor Antigen
12%
Basophil Activation
9%
Plasmablast
9%
Memory B Cell
9%
Interleukin 10
9%
Immunoglobulin A
9%
Humoral Immunity
9%
Programmed Death 1 Ligand 1
9%
Cancer Growth Factor
9%
Antibody Affinity
9%
Proinflammatory Cytokine
9%
Glycan
9%
Cancer Cell
8%
Antineoplastic Activity
8%
Medline
7%
Web of Science
7%
Medicine and Dentistry
Neoplasm
82%
Ovarian Cancer
76%
Macrophage
63%
Folate Receptor 1
44%
Disease Burden
38%
Cancer Tissue
38%
Immunosuppressive Drug
38%
Immunoglobulin E Antibody
38%
Repolarization
38%
Cell Interaction
38%
Melanoma
38%
Proteochondroitin Sulfate
38%
Immunotherapy
38%
Breast Cancer
38%
Effector Cell
38%
Cancer Growth
38%
Immunoglobulin E
30%
Triple Negative Breast Cancer
25%
Natural Killer Cell
19%
Tumor
19%
Malignant Neoplasm
13%
Antibody Design
12%
Point Mutation
12%
Neoadjuvant Chemotherapy
12%
Monoclonal Antibody
11%
Tumor Antigen
10%
Cell Surface
9%
Immune Response
9%
Antifolate
7%
RNA Sequencing
7%
Phase I Trials
7%
Ex Vivo
7%
Fucose
6%
Tumor Microenvironment
6%
Glycan
6%
Diseases
6%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
6%
Immunocompetent Cell
6%
Tumor Xenograft
6%
Fc Receptor
6%
Cytokine Production
6%
Antibody Affinity
6%
Therapy Effect
6%
Biochemistry, Genetics and Molecular Biology
Immunoglobulin E
57%
Folate Receptor 1
51%
Anticancer
47%
Disease Burden
38%
B Cell
38%
Macrophage
38%
Natural Killer Cell
28%
Glycoengineering
28%
Wild Type
19%
Point Mutation
19%
Tumor Antigen
13%
Monoclonal Antibody
13%
Solution and Solubility
11%
Memory B Cell
9%
Cancer Growth Factor
9%
Immunoglobulin A
9%
Humoral Immunity
9%
Interleukin 10
9%
Fucose
9%
Polysaccharides
9%
Proinflammatory Cytokine
9%
Cytokine Production
9%
Antibody Affinity
9%
Fc Receptor
9%
Immunocompetent Cell
9%
Normal Human
8%
Antifolate
7%